Biocryst Pharmaceuticals (BO1.STU) Q3 2026 Earnings

5AugConfirmed
Q2 2026
Q3 2026
-2.54
-1.6
-0.67
0.26

Details

Expected EPS
0.1334227466
Actual EPS
0.259611
Surprise EPS
0.13
Surprise Percent
+94.58%

Description

Biocryst Pharmaceuticals (BO1.STU) has reported earnings of 0.259611 per share for Q3 2026.

0 Comments

Share your thoughts